DIHEXA is an oligopeptide drug and novel compound being studied for its ability to support brain repair and regeneration in conditions like Alzheimer’s, Parkinson’s, and stroke-related impairments.
By enhancing hepatocyte growth factor (HGF) activity at c-Met receptors, DIHEXA promotes neural plasticity and the formation of new synapses. This unique mechanism shows promise in improving memory, motor function, and cognitive decline, offering hope for patients facing these challenging conditions. It also facilitates the formation of new functional synapses, effectively strengthening synaptic connectivity. As a result, Dihexa shows promise in improving memory and motor functions while delaying cognitive decline and movement dysfunctions caused by these debilitating conditions.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.